Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
4.840
-0.120 (-2.42%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Bolt Biotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 9 | 10 | 20 | 43 | 49 | 183 | |
| Market Cap Growth | -25.06% | -48.75% | -51.84% | -13.15% | -73.20% | - | |
| Enterprise Value | 5 | 2 | -15 | -56 | -99 | -5 | |
| Last Close Price | 4.84 | 5.47 | 10.70 | 22.40 | 26.00 | 98.00 | |
| PS Ratio | 1.21 | 1.36 | 2.66 | 5.40 | 8.55 | 145.00 | |
| PB Ratio | 0.35 | 0.40 | 0.36 | 0.38 | 0.28 | 0.73 | |
| P/TBV Ratio | 0.35 | 0.40 | 0.36 | 0.38 | 0.28 | 0.73 | |
| EV/Sales Ratio | 0.62 | 0.28 | - | - | - | - | |
| Debt / Equity Ratio | 0.87 | 0.87 | 0.44 | 0.18 | 0.13 | 0.10 | |
| Net Debt / Equity Ratio | -0.17 | -0.17 | -0.39 | -0.73 | -0.85 | -0.65 | |
| Net Debt / EBITDA Ratio | 0.14 | 0.14 | 0.33 | 1.10 | 1.65 | 1.77 | |
| Net Debt / FCF Ratio | 0.11 | 0.11 | 0.36 | 1.18 | 1.86 | 2.73 | |
| Asset Turnover | 0.10 | 0.10 | 0.06 | 0.04 | 0.02 | 0.01 | |
| Quick Ratio | 3.38 | 3.38 | 3.06 | 5.03 | 7.31 | 8.73 | |
| Current Ratio | 3.59 | 3.59 | 3.21 | 5.17 | 7.47 | 8.87 | |
| Return on Equity (ROE) | -79.75% | -79.75% | -74.28% | -48.69% | -41.79% | -71.52% | |
| Return on Assets (ROA) | -27.68% | -27.68% | -32.88% | -24.57% | -21.08% | -32.74% | |
| Return on Capital Employed (ROCE) | -71.70% | -71.70% | -81.50% | -54.70% | -44.10% | -32.40% | |
| Earnings Yield | -358.87% | -318.00% | -308.19% | -162.73% | -179.94% | -53.96% | |
| FCF Yield | -429.25% | -380.37% | -299.47% | -163.99% | -160.25% | -32.52% | |
| Buyback Yield / Dilution | 2.06% | 2.06% | -0.98% | -1.21% | -12.54% | -1479.05% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.